CSIMarket
 
Mesa Laboratories Inc  (MLAB)
Other Ticker:  
 
 
Price: $101.0800 $1.23 1.232%
Day's High: $103.25 Week Perf: -5.38 %
Day's Low: $ 98.33 30 Day Perf: 4.06 %
Volume (M): 53 52 Wk High: $ 187.75
Volume (M$): $ 5,307 52 Wk Avg: $122.29
Open: $99.21 52 Wk Low: $82.86



 Market Capitalization (Millions $) 545
 Shares Outstanding (Millions) 5
 Employees 276
 Revenues (TTM) (Millions $) 213
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 3

Mesa Laboratories Inc

Mesa Laboratories, Inc. was incorporated under the laws of the State of Colorado on March 26, 1982. We pursue a strategy of focusing primarily on quality control products, which are sold into niche markets that are driven by regulatory requirements. We prefer markets that have limited competition where we can establish a commanding presence and achieve high gross margins. We are organized into three divisions across six physical locations. Our Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. Our Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Our Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments.

Our Lakewood, Colorado, and Butler, New Jersey, facilities manufacture our Instruments Division products which include the DataTrace®, DialyGuard®, DryCal®, Torqo®, SureTorque® and BGI brands. Our Omaha, Nebraska, and Bozeman, Montana locations manufacture our Biological Indicators Division products which include the Mesa, PCD® and Apex® brands, while our Lakewood, Colorado, facility also manufactures our Continuous Monitoring Division products which include CheckPoint® and AmegaView brands.

Our philosophy is to manufacture exceptional quality products and provide a high level of on-going service for those products. Our revenues come from two main sources – product sales and services. Our strategic goals involve continuing to grow revenues and profits through three key strategies – a) improving our distribution channels, b) introducing new products to the market, and c) seeking out companies or product lines to acquire.

Product sales are dependent on several factors, including general economic conditions, both domestic and international, customer capital spending trends, competition, introduction of new products and acquisitions. Biological indicator products are disposable and are used on a routine basis for quality control, thus product sales are less sensitive to general economic conditions. Instrument products and continuous monitoring systems have a longer life, and their purchase by our customers is somewhat discretionary, so sales are more sensitive to general economic conditions. Service demand is driven by our customers’ quality control and regulatory environments, which require periodic repair and recalibration or certification of our instrument products and continuous monitoring systems. We typically evaluate costs and pricing annually. Our policy is to price our products competitively and, where possible, we try to pass along cost increases in order to maintain our margins.



   Company Address: 12100 West Sixth Avenue Lakewood 80228 CO
   Company Phone Number: 987-8000   Stock Exchange / Ticker: NASDAQ MLAB
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

Mesa Labs Sustains Commitment to Responsible Business Practices with Second Annual ESG Program Brochure

Published Fri, Mar 15 2024 11:00 AM UTC

In a bid to reinforce its dedication to ethical and sustainable business practices, Mesa Laboratories, Inc. has unveiled its second annual Environmental, Social, and Governance (ESG) Program Brochure. With a focus on protecting vulnerable communities and fostering environmental stewardship, social responsibility, and strong corporate governance, Mesa Labs is positioning itse...

Mesa Laboratories Inc

Mesa Laboratories Inc Delivers Impressive Quarterly Earnings Despite Revenue Decrease

Mesa Laboratories Inc, a global leader in life science tools and quality control solutions, recently announced its financial results for the third fiscal quarter ended December 31, 2023. Despite a decrease in revenue, the company managed to significantly increase its earnings per share, with net profit per share soaring by 387.5% to $0.39 per share. This positive financial performance is a testament to the company's ability to adapt and thrive in challenging market conditions.
However, it's worth noting that Mesa Laboratories Inc stock has experienced a downward trend in the past 5 trading days, with a decrease of -2.52%. This brings the year-to-date performance to -11.54%. Furthermore, the stock is trading only 13.4% above its 52-week low, indicating potential challenges ahead for the company.

Dividend

Mesa Laboratories to Reward Shareholders with Quarterly Dividend Amidst Challenging Year-end Performance

Published Tue, Oct 3 2023 12:01 PM UTC



LAKEWOOD, Colo., Oct. 03, 2023 - Mesa Laboratories, Inc. (NASDAQ:MLAB) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share of common stock. This noteworthy declaration is set to impact shareholders, offering them both reassurance and potential rewards.
The dividend will be payable on December 15, 2023, to sha...

Mesa Laboratories Inc

Mesa Laboratories Inc. Sees Modest 0.381% First Quarter Revenue Increase in 2024 Despite Earnings Per Share Fall

/>This article evaluates the recent financial performance of Mesa Laboratories Inc., focusing on the company's Q2 2023 results. The report analyzes key financial metrics such as earnings per share (EPS), revenue, net loss, inventories, and accounts receivable. Additionally, it provides a brief context by highlighting Mesa Laboratories Inc.'s recent stock performance.
Financial Results Analysis:
1. EPS and Net Loss:
In Q2 2023, Mesa Laboratories Inc. reported a loss of $0.10 per share, a significant improvement from the loss of $0.27 per share in the same period last year. Additionally, the current EPS represents a decline from the previous quarter's $0.11 per share. The company's net loss for the quarter was $-0.549 million, a positive shift from the $-1.438 million net loss reported in the corresponding period a year ago.

Mesa Laboratories Inc

Mesa Laboratories Inc. Sees Income Surge to $0.11 Per Share, Boosted by $0.89 Million Tax Provisions

Mesa Laboratories Inc, the Colorado-based electronic instruments and controls company, is showing signs of profitability according to their latest financial reports. The newest fiscal period saw a positive income of $0.11 per share - a significant improvement from $-0.33 a year before. Additionally, income grew by 37.02% from $0.08 per share in the previous reporting period.
While revenue decreased by -5.584% to $55.59 million compared to the same reporting season the year before, sequentially revenue grew by 2.402% from $54.29 million. However, the company expressed satisfaction with their new bottom-line, achieving $0.611 million in the most recent fiscal period. This is a marked improvement from a net shortfall of $-1.784 million reported in the same period a year ago.






 

Mesa Laboratories Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com